tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

GRCS Swings to Loss and Negative Equity but Forecasts Recovery in FY2026

Story Highlights
GRCS Swings to Loss and Negative Equity but Forecasts Recovery in FY2026

Claim 50% Off TipRanks Premium

GRCS, Inc. ( (JP:9250) ) has shared an update.

GRCS Inc. reported a modest 1.4% increase in net sales to ¥3,333 million for the fiscal year ended November 30, 2025, but swung to a significant loss, posting an operating loss of ¥67 million and a loss attributable to owners of the parent of ¥527 million, compared with a profit in the previous year. The company’s financial position deteriorated, with total assets declining to ¥1,713 million, net assets turning negative at ¥95 million, and the equity ratio falling to -7.9%, while it continued its policy of not paying dividends. Despite the weak results and negative equity, GRCS maintains a positive outlook for the fiscal year ending November 30, 2026, forecasting a 10.3% rise in net sales to ¥3,678 million and a return to profitability with operating profit of ¥119 million and basic earnings per share of ¥50.33, signaling an anticipated recovery that will be closely watched by investors concerned about balance sheet strength and future growth potential.

The most recent analyst rating on (JP:9250) stock is a Hold with a Yen1326.00 price target. To see the full list of analyst forecasts on GRCS, Inc. stock, see the JP:9250 Stock Forecast page.

More about GRCS, Inc.

GRCS Inc. is a Japan-based company listed on the Tokyo Stock Exchange that operates under Japanese GAAP and provides governance, risk, and compliance-related solutions and services. The company focuses on enterprise clients seeking to strengthen internal controls, security, and regulatory compliance, positioning itself within the broader IT and risk management services industry.

Average Trading Volume: 2,431

Technical Sentiment Signal: Sell

Current Market Cap: Yen1.26B

For detailed information about 9250 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1